The expression of CKLF1 in ischemic stroke began 8 h after stroke and peaked 2 to 3 days after stroke, accordingly, the treatment window for the CKLF1-neutralizing antibody was defined as four days following stroke, which included the peak period of CKLF1 production and neutrophil infiltration. The gene discussed is CKLF; the disease is stroke disorder.